TP53 and small cell lung carcinoma: We are further investigating the mechanism of this role, but it likely stems from both metabolic modulation in the highly active SCLC tumor and lack of apoptotic signaling machinery with loss of p53 and Rb in high grade neuroendocrine tumors.